← Investments

Portfolio company

Kincell Bio

United States · £17.4m raised

Raised

£17.4m

Latest stage

Growth

Rounds recorded

1

Backed by

1 investor

Sectors

Digital Health

About

The company provides manufacturing, analytical development and regulatory services for cell therapy developers from early clinical stages through to commercial launch.

Source

Funding history · 1

  1. 2025-05-15Growth$22m

Similar companies